Hostname: page-component-76fb5796d-2lccl Total loading time: 0 Render date: 2024-04-25T13:56:59.733Z Has data issue: false hasContentIssue false

Factores asociados con la depresión en la enfermedad de Parkinson: un estudio transversal en una población polaca

Published online by Cambridge University Press:  12 May 2020

Hubert M. Wichowicz
Affiliation:
Primer Departamento de Psiquiatría, Universidad de Medicina, Gdañsk, Dębinki 7 St., 80-952 , Gdañsk, Polonia
Jarosław Sławek
Affiliation:
Departamento de Neurocirugía, División de Cirugía Funcional y Trastornos del Movimiento, Universidad Médica, Gdañsk, Polonia
Mirosława Derejko
Affiliation:
Primer Departamento de Psiquiatría, Universidad de Medicina, Gdañsk, Dębinki 7 St., 80-952 , Gdañsk, Polonia
Wiesław Jerzy Cubała
Affiliation:
Primer Departamento de Psiquiatría, Universidad de Medicina, Gdañsk, Dębinki 7 St., 80-952 , Gdañsk, Polonia
Get access

Resumen

Objetivo

El propósito de este estudio era evaluar la prevalencia y los factores que influyen en la depresión en los pacientes con enfermedad de Parkinson (EP) en una muestra transversal de pacientes polacos de una clínica ambulatoria.

Materiales y métodos

Se incluyó en este estudio a cien pacientes consecutivos con EP; 35 de ellos cumplían los criterios del DSMIV para depresión mayor y se evaluó su gravedad con la Escala de Evaluación de la Depresión de Montgomery-Åsberg (MADRS). Se realizó una entrevista estructurada y una exploración neurológica que incluía la Escala de Hoehn y Yahr (H-Y), la Escala de Discapacidad de Schwab-England, las partes II, III y IV de la Escala Unificada de Evaluación de la Enfermedad de Parkinson (UPDRS) y el Mini-Examen del Estado Mental (MMSE). Se analizaron los parámetros obtenidos entre los pacientes con EP con y sin depresión.

Resultados

La prevalencia de la depresión en la EP en la población polaca se estableció en el nivel de 35%. Los pacientes con EP y depresión puntuaron significativamente más alto en todas las escalas de la UPDRS (excepto para la subescala de fluctuación clínica) y en la H-Y. La EP con depresión se asociaba también con una duración mayor de la EP, dosis más altas de equivalentes de L-dopa, la edad de los pacientes, el deterioro general de la vida diaria en la Escala de Discapacidad de Schwab y England, una puntuación baja en el MMSE y mayores fluctuaciones clínicas. Sin embargo, esas seis diferencias no fueron significativas.

Conclusiones

La tasa de prevalencia de la depresión entre los pacientes con EP en una población polaca es ligeramente más baja que en la mayoría de los demás estudios publicados. Esto puede derivarse de los estrictos criterios de selección, el uso de medidas de evolución específicas y la aplicación de los criterios restringidos para la depresión que se aplicaron.

Type
Artículo original
Copyright
Copyright © European Psychiatric Association 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bibliografía

[1]Aarsland, DCummings, JDepression in Parkinson's disease. Act Psychiatr Scand 2002;106:161–2.CrossRefGoogle ScholarPubMed
[2]Allain, HSchuck, SMauduit, NDepression in Parkinson's disease. BMJ 2000;320:1287–8.CrossRefGoogle ScholarPubMed
[3]American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington DC: APA; 1994.Google Scholar
[4]Broks, DJDoder, MDepression in Parkinson disease. Curr Opin Neurol 2001;14:465–70.CrossRefGoogle Scholar
[5]Brown, RGMacCarthy, BPsychiatric morbidity in patients with Parkinson's disease. Psychol Med 1990;20:7787.CrossRefGoogle ScholarPubMed
[6]Brown, RGMacCarthy, BGotham, AMDer, GJMarsden, CDDepression and disability in Parkinson's disease: a follow-up study of 132 cases. Psychol Med 1988;18:4955.CrossRefGoogle ScholarPubMed
[7]Brown, GLWilson, WPParkinsonism and depression. South Med J 1972;65:540–5.CrossRefGoogle ScholarPubMed
[8]Celesia, GSWanamaker, WMPsychiatric disturbances in Parkinson disease. Dis Nerv Syst 1972;33:577–83.Google Scholar
[9]Cummings, JLDepression and Parkinson disease: a review. Am J Psychiatry 1992;149:443–54.Google ScholarPubMed
[10]Dooneief, GMirabello, EBell, KMarder, KStern, YMayeux, RAn estimate of the incidence of depression in idiopathic Parkinson's disease. Arch Neurol 1992;49:305–7.CrossRefGoogle ScholarPubMed
[11]Ehmann, TSBeninger, RJGawel, MJRiopelle, RJDepressive symptoms in Parkinson's disease: a comparison with disabled control subjects. J Geriatr Psychiatr Neurol 1990;2:39.CrossRefGoogle Scholar
[12]El-Awar, MFreedman, MSeeman, PGoldenberg, LLittle, JSolomon, PResponse of tardive and L-dopa-induced dyskinesias to antidepressants. Can J Neurol Sci 1987;14:629–31.Google Scholar
[13]Fahn, SElton, RLMembers of the UPDRS Development Committee. Unified Parkinson's disease rating scale. In: Fahn, SMarsden, CDCalne, DB editors. Recent Developments in Parkinson's Disease. Florham Park, NJ: Mac Millan Healthcare Information; 1987. p. 153–6.Google Scholar
[14]Folstein, MFFolstein, SEMc Hugh, PRMini-mental State. A practical method for grading the cognitive State of patients for the clinician. J Psychiatr Res 1975;12:189–98.CrossRefGoogle Scholar
[15]Friedenberg, DLCummings, JLParkinson's disease, depression, and the on-off phenomenon. Psychosomatics 1989;30:94–9.CrossRefGoogle ScholarPubMed
[16]Gotham, AMBrown, RGMarsden, CDDepression in Parkinson's disease: a quantitative and qualitative analysis. J Neurol Neurosurg Psychiatry 1986;49:381–9.CrossRefGoogle ScholarPubMed
[17]Hoehn, MMYabr, MDParkinsonism: onset, progression and mortality. Neurology 1967;17:427 42.CrossRefGoogle ScholarPubMed
[18]Hom, SSome psychological factors in parkinsonism. J Neurol Neurosurg Psychiatry 1974;37:2731.Google Scholar
[19]Hughes, AJDaniel, SEKilford, LLees, AJAccuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;51:745–52.Google Scholar
[20]Lauterbach, ECSethi, KDDifferential correlates of mood and cognition in dystonia and Parkinson's disease. Mov Disord 2002;17(suppl 5):S223.Google Scholar
[21]Leentjens, AVerhey, FLousberg, RSpitsbergen, HWilmink, FThe validity of Hamilton and Montgomery-Asberg depression rating scale and diagnostic tools for depression in Parkinson's disease. Int J Geriatr Psychiatry 2000;15:644–9.3.0.CO;2-L>CrossRefGoogle ScholarPubMed
[22]Maride, RANutt, JGCarter, JHMood and anxiety fluctuation in Parkinon's disease associated with levodopa infusion: Preliminary fmdings. Mov Disord 1995;10:329–32.Google Scholar
[23]Mayeux, RYaakov, BARosen, JLeventhal, JPrevalance, Etiology, and Treatment of Depression in Parkinson's Disease. Biol Psychiatry 1981;31:645–50.Google Scholar
[24]McDonald, WMRichard, IHDeLong, MRPrevalance, Etiology, and Treatment of Depression in Parkinson's Disease. Biol Psychiatry 2003;54:363–75.CrossRefGoogle Scholar
[25]Mindham, RHSPsychiatric symptoms in parkinsonism. J Neurol Neurosurg Psychiatry 1970;33:188–91.CrossRefGoogle ScholarPubMed
[26]Mindham, RHSMarsden, CDParkes, JDPsychiatric symptoms during l-dopa therapy for Parkinson's disease and their relationship to physical disability. Psychol Med 1976;6:2333.CrossRefGoogle ScholarPubMed
[27]Montgomery, SAAsberg, MA new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:322–89.CrossRefGoogle ScholarPubMed
[28]Nissenbaum, HQuinn, NPBrown, RGToone, BGotham, AMMarsden, CDMood swing associated with the “on-off” phenomenon in Parkinson's disease. Psychol Med 1987;17:899904.Google Scholar
[29]Poewe, WLuginger, EDepression in Parkinson's disease: impediments to recognition and treatment options. Neurology 1999; 52(Suppl.3):S2–6.Google ScholarPubMed
[30]Racette, BAHartlein, JMHershey, TMink, JWPerlamuter, JSBlack, KJClinical features and comorbidity of mood fluctuations in Parkinson's disease. J Neuropsychiatry Clin Neurosci 2002;14:438–42.CrossRefGoogle ScholarPubMed
[31]Ranoux, DDepression et maladie de Parkinson. Encephale 26 (Spec 3): 2226.Google Scholar
[32]Richard, IHJustus, AWKurlan, RRelationship between mood and motor fluctuations in Parkinson's disease. J Neuropsychiatry Clin Neurosci 2001;13:3541.CrossRefGoogle ScholarPubMed
[33]Santamaria, JTolosa, EValles, AParkinson's disease with depression: a possible subgroup of idiopathic parkinsonism. Neurology 1986;36:1130–3.CrossRefGoogle ScholarPubMed
[34]Schrag, AHahanshahi, MQuinn, NHow does Parkinson's Disease affect quality of life? A comparison with quality of life in the general population. Mov Disord 2000;6:1112–8.3.0.CO;2-A>CrossRefGoogle Scholar
[35]Schwab, RSEngland, ACProjection technique for evaluating surgery in Parkinson's disease. In: Gillingham, FJDonaldson, IML editors. Third Symposinm on Surgery in Parkinson's Disease. Edinburgh: Livingstone; 1969. p. 152–7.Google Scholar
[36]Slawek, JDerejko, MLass, PFactors affecting the quality of life of patients with idiopathic Parkinson's disease-a cross-sectional study in an outpatient clinic attendees. Parkinsonism Relat Disord 2005; 11 (7):465–8.CrossRefGoogle Scholar
[37]Starkstein, SEPreziosi, TJBolduc, PLRobinson, RGDepression in Parkinson's disease. J Nerv Ment Dis 1990;178:2731.CrossRefGoogle ScholarPubMed
[38]Starkstein, SEMayberg, HSLeiguarda, RPreziosi, TJRobinson, RGA prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1992;55:377–82.CrossRefGoogle ScholarPubMed
[39]Tandberg, ELarsen, JPAarsland, DLaake, KCummings, JLThe occurrence of depression in Parkinson's disease. A communitybased study. Arch Neurol 1996;53:175–9.CrossRefGoogle Scholar
[40]Zach, MFriedman, ASlawek, JDerejko, MQuality of life in Polish patients with long-lasting Parkinson's disease. Mov Disord 2004;19(6):667–72.Google ScholarPubMed